Abbott Laboratories Gross Margin 2006-2019 | ABT
Current and historical gross margin for Abbott Laboratories (ABT) over the last 10 years. The current gross profit margin for Abbott Laboratories as of September 30, 2019 is %.
| Abbott Laboratories Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2019-09-30 | $31.36B | $18.37B | 58.58% |
| 2019-06-30 | $30.94B | $18.14B | 58.64% |
| 2019-03-31 | $30.72B | $17.92B | 58.34% |
| 2018-12-31 | $30.58B | $17.87B | 58.45% |
| 2018-09-30 | $30.40B | $17.61B | 57.91% |
| 2018-06-30 | $29.58B | $17.07B | 57.71% |
| 2018-03-31 | $28.45B | $16.03B | 56.36% |
| 2017-12-31 | $27.39B | $14.98B | 54.70% |
| 2017-09-30 | $25.13B | $13.63B | 54.21% |
| 2017-06-30 | $23.61B | $12.69B | 53.75% |
| 2017-03-31 | $22.30B | $12.29B | 55.09% |
| 2016-12-31 | $20.85B | $11.76B | 56.39% |
| 2016-09-30 | $20.71B | $11.79B | 56.93% |
| 2016-06-30 | $20.56B | $11.68B | 56.83% |
| 2016-03-31 | $20.39B | $11.59B | 56.82% |
| 2015-12-31 | $20.41B | $11.66B | 57.13% |
| 2015-09-30 | $20.57B | $11.70B | 56.85% |
| 2015-06-30 | $20.50B | $11.55B | 56.32% |
| 2015-03-31 | $20.39B | $11.36B | 55.74% |
| 2014-12-31 | $20.25B | $11.03B | 54.47% |
| 2014-09-30 | $18.90B | $10.06B | 53.21% |
| 2014-06-30 | $18.65B | $9.87B | 52.92% |
| 2014-03-31 | $19.03B | $10.00B | 52.53% |
| 2013-12-31 | $19.66B | $10.46B | 53.23% |
| 2013-09-30 | $18.84B | $9.92B | 52.68% |
| 2013-06-30 | $19.28B | $10.13B | 52.55% |
| 2013-03-31 | $19.14B | $10.17B | 53.13% |
| 2012-12-31 | $19.05B | $10.15B | 53.29% |
| 2012-09-30 | $26.24B | $15.18B | 57.86% |
| 2012-06-30 | $30.79B | $18.25B | 59.27% |
| 2012-03-31 | $35.09B | $21.05B | 59.99% |
| 2011-12-31 | $38.85B | $23.31B | 60.00% |
| 2011-09-30 | $38.44B | $22.69B | 59.03% |
| 2011-06-30 | $37.30B | $21.78B | 58.40% |
| 2011-03-31 | $36.51B | $21.32B | 58.39% |
| 2010-12-31 | $35.17B | $20.50B | 58.30% |
| 2010-09-30 | $33.99B | $19.58B | 57.62% |
| 2010-06-30 | $33.08B | $19.05B | 57.60% |
| 2010-03-31 | $31.74B | $18.14B | 57.13% |
| 2009-12-31 | $30.76B | $17.56B | 57.06% |
| 2009-09-30 | $29.92B | $17.32B | 57.88% |
| 2009-06-30 | $29.66B | $17.07B | 57.53% |
| 2009-03-31 | $29.48B | $16.89B | 57.30% |
| 2008-12-31 | $29.53B | $16.92B | 57.29% |
| 2008-09-30 | $28.80B | $16.20B | 56.27% |
| 2008-06-30 | $27.68B | $15.57B | 56.26% |
| 2008-03-31 | $26.74B | $14.94B | 55.90% |
| 2007-12-31 | $25.92B | $14.49B | 55.93% |
| 2007-09-30 | $25.52B | $13.98B | 54.78% |
| 2007-06-30 | $24.71B | $13.65B | 55.23% |
| 2007-03-31 | $23.84B | $13.20B | 55.34% |
| 2006-12-31 | $22.48B | $12.66B | 56.34% |
| 2006-09-30 | $21.70B | $12.36B | 56.93% |
| 2006-06-30 | $21.51B | $11.88B | 55.22% |
| 2006-03-31 | $21.54B | $11.66B | 54.14% |
| 2005-12-31 | $22.34B | $11.70B | 52.36% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $151.168B | $30.578B |
| Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $151.583B | 20.94 |
| Stryker (SYK) | United States | $76.313B | 25.66 |
| Boston Scientific (BSX) | United States | $61.440B | 29.00 |
| Baxter (BAX) | United States | $42.463B | 25.75 |
| Essilor Luxottica (ESLOY) | France | $33.468B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $30.550B | 19.17 |
| Terumo (TRUMY) | Japan | $27.062B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.531B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.294B | 39.03 |
| ResMed (RMD) | United States | $21.653B | 39.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.279B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $19.151B | 0.00 |
| Insulet (PODD) | United States | $11.373B | 541.06 |
| Bio-Rad Laboratories (BIO) | United States | $11.201B | 53.76 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.616B | 0.00 |
| William Demant Holdings (WILYY) | Denmark | $7.531B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.203B | 21.24 |
| Perrigo (PRGO) | Ireland | $7.117B | 13.27 |
| Canopy Growth (CGC) | Canada | $6.501B | 0.00 |
| Haemonetics (HAE) | United States | $6.146B | 41.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.743B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.276B | 0.00 |
| NuVasive (NUVA) | United States | $3.890B | 30.64 |
| ICU Medical (ICUI) | United States | $3.830B | 24.97 |
| Neogen (NEOG) | United States | $3.545B | 59.33 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.165B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.121B | 0.00 |
| Quidel (QDEL) | United States | $2.954B | 28.04 |
| Aurora Cannabis (ACB) | Canada | $2.648B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.432B | 54.89 |
| Agios Pharmaceuticals (AGIO) | United States | $2.411B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.577B | 0.00 |
| InMode (INMD) | Israel | $1.516B | 0.00 |
| AtriCure (ATRC) | United States | $1.226B | 0.00 |
| Aphria (APHA) | $1.187B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.162B | 23.28 |
| Phibro Animal Health (PAHC) | United States | $0.994B | 18.61 |
| NanoString Technologies (NSTG) | United States | $0.944B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.802B | 20.04 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.771B | 29.55 |
| TG Therapeutics (TGTX) | United States | $0.709B | 0.00 |
| Quanterix (QTRX) | United States | $0.705B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.698B | 39.25 |
| PetIQ (PETQ) | United States | $0.675B | 16.46 |
| Omeros (OMER) | United States | $0.655B | 0.00 |
| Cerus (CERS) | United States | $0.574B | 0.00 |
| Surmodics (SRDX) | United States | $0.570B | 59.24 |
| HEXO (HEXO) | $0.537B | 0.00 | |
| OraSure Technologies (OSUR) | United States | $0.492B | 29.52 |
| Owens & Minor (OMI) | United States | $0.474B | 17.53 |
| MacroGenics (MGNX) | United States | $0.474B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.405B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.396B | 28.71 |
| Meridian Bioscience (VIVO) | United States | $0.396B | 13.62 |
| BioLife Solutions (BLFS) | United States | $0.331B | 134.92 |
| Zynex (ZYXI) | United States | $0.329B | 37.22 |
| Bovie Medical (APYX) | United States | $0.275B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.269B | 0.00 |
| United Health Products (UEEC) | United States | $0.249B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.242B | 25.52 |
| Vapotherm (VAPO) | United States | $0.227B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.195B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.192B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.164B | 0.00 |
| Chimerix (CMRX) | United States | $0.151B | 0.00 |
| Female Health (VERU) | United States | $0.148B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.141B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.128B | 0.00 |
| Fonar (FONR) | United States | $0.128B | 9.03 |
| MTech Acquisition (KERN) | United States | $0.114B | 0.00 |
| United-Guardian (UG) | United States | $0.091B | 23.15 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.080B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.069B | 0.00 |
| Nephros (NEPH) | United States | $0.064B | 0.00 |
| Surface Oncology (SURF) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.024B | 0.00 |
| Senestech (SNES) | United States | $0.017B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.015B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.013B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.012B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
